scorecardresearch
Business Today
Subscribe
PMS Today US News India UPSTART Weather BT Shorts NRI Education Election
BT Golf BT Mindrush BT Best Banks
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • Economic Indicators
News
Markets
Stocks
Shilpa Medicare Ltd

Feedback
Shilpa Medicare Ltd

Shilpa Medicare Ltd (SHILPAMED) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 174,159
Apr 07, 2025 12:56 IST- Closed
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹582.15
₹-47.45 (-7.52%)
₹555 Low
Today’s Performance
₹594 High
₹417.6 Low
52 Week’s Performance
₹959.5 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day -7.52%
  • 1 Week -5.09%
  • 1 Month 1.15%
  • 3 Months -22.71%
  • 6 Months -21.53%
  • 1 Year 27.50%
  • 3 Years 14.84%
  • 5 Years 17.33%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 1.00
  • Beta 1.26
  • 52-Week Low (₹) 417.60
  • 52-Week High (₹) 959.50
  • Price-to-Book (X)* 2.65
  • Dividend Yield (%) 0.00
  • Price-to-Earnings (P/E) (X)* 69.75
  • Earnings Per Share (₹) 9.03
  • Sector Price Earning (X)* 33.02
  • Market Cap (₹ Cr.)* 6,156.92
  • * Vaues as of last close price

COMPETITORS

BT TV

Trump’s Tariffs Reach Remote Australia | Even The PM Is Confused! 1:56 Trump’s Tariffs Reach Remote Australia | Even The PM Is Confused!
Sneha Poddar’s Bullish Picks After Market Fall | What To Buy Now? 1:40 Sneha Poddar’s Bullish Picks After Market Fall | What To Buy Now?
Jayant Dasgupta on Trump Tariffs | How Will India Respond to Rising Trade Pressures? 1:30 Jayant Dasgupta On Trump Tariffs | How Will India Respond To Rising Trade Pressures?
PM Modi Meets Bangladesh’s Muhammad Yunus In Bangkok, First Since Sheikh Hasina’s Ouster 2:33 PM Modi Meets Bangladesh’s Muhammad Yunus In Bangkok, First Since Sheikh Hasina’s Ouster
India’s Growth vs Trump’s Tariffs: Rajani Sinha on GDP Impact, Export Pressure & Global Slowdown 1:33 India’s Growth Vs Trump’s Tariffs: Rajani Sinha On GDP Impact, Export Pressure & Global Slowdown
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

  • NSE
  • BSE
Oct 21, 2022 PURCHASE
NALINI DHIRAJLAL PAREKH
  • Qty 835000
  • Average Price ₹330.70
Oct 21, 2022 Sell
PIVOTAL BUSINESS MANAGERS LLP
  • Qty 835000
  • Average Price ₹330.70
Oct 21, 2022 Sell
PIVOTAL BUSINESS MANAGERS LLP
  • Qty 370000
  • Average Price ₹330.70
Oct 21, 2022 PURCHASE
MALIKA BIMAL PAREKH
  • Qty 303333
  • Average Price ₹330.70
Oct 21, 2022 Sell
PIVOTAL BUSINESS MANAGERS LLP
  • Qty 306667
  • Average Price ₹330.70
Oct 21, 2022 PURCHASE
BIMAL JASVANTLAL PAREKH
  • Qty 370000
  • Average Price ₹330.70
*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Feb 21, 2024 PURCHASE
GRAVITON RESEARCH CAPITAL LLP
  • Qty 482523
  • Average Price ₹443.95
Feb 21, 2024 Sell
GRAVITON RESEARCH CAPITAL LLP
  • Qty 482523
  • Average Price ₹444.09
Feb 20, 2024 Sell
TA FII INVESTORS LIMITED
  • Qty 500000
  • Average Price ₹422.22
Feb 19, 2024 Sell
TA FII INVESTORS LIMITED
  • Qty 1345000
  • Average Price ₹407.05
Feb 19, 2024 Sell
GRAVITON RESEARCH CAPITAL LLP
  • Qty 578067
  • Average Price ₹404.48
Feb 19, 2024 PURCHASE
GRAVITON RESEARCH CAPITAL LLP
  • Qty 578067
  • Average Price ₹404.63
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Shilpa Medicare Ltd share price previously?
Shilpa Medicare Ltd share price was down by -7.52% from the previous closing price of ₹629.60.
Who are peers of Shilpa Medicare Ltd?
The peers of Shilpa Medicare Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd,
Who is/are the promoter/promoters of Shilpa Medicare Ltd?
The promotor/promotors of Shilpa Medicare Ltd are Omprakash Inani, Vishnukant Bhutada, Sharath Reddy Kalakota, Arvind Vasudeva, Hetal Gandhi, Ritu Tiwary, Kamal K Sharma, Anita Bandyopadhyay.
What has been 52-week high of Shilpa Medicare Ltd stocks?
The highest price of Shilpa Medicare Ltd stock is ₹959.50 in the last 52-week.
What is the share price of Shilpa Medicare Ltd (SHILPAMED) today on NSE?
As on Apr 07, 2025, Shilpa Medicare Ltd (SHILPAMED)’s share price on NSE is Rs 582.15
What is the market cap of Shilpa Medicare Ltd (SHILPAMED?)
The current market capitalisation of Shilpa Medicare Ltd (SHILPAMED) is 6,156.92 crores
What is Shilpa Medicare Ltd Share symbol?
The symbol of Shilpa Medicare Ltd is SHILPAMED.
What is the PE ratio of Shilpa Medicare Ltd (SHILPAMED)?
The current PE ratio of Shilpa Medicare Ltd (SHILPAMED) is 69.75.
What is the PB ratio of Shilpa Medicare Ltd (SHILPAMED)?
The current PB ratio of Shilpa Medicare Ltd (SHILPAMED) is 2.65.
Today’s High & Low share prices of Shilpa Medicare Ltd (SHILPAMED) on NSE?
Today, the share price of Shilpa Medicare Ltd (SHILPAMED) on NSE touched a high of Rs 594 and a low of Rs 555
What price did Shilpa Medicare Ltd (SHILPAMED) shares open on the NSE today?
On NSE, the share price of Shilpa Medicare Ltd (SHILPAMED) opened at Rs 555
What is the 52-week high of Shilpa Medicare Ltd (SHILPAMED)?
The 52-week high price of Shilpa Medicare Ltd (SHILPAMED) is Rs 959.5
What is the 52-week low of Shilpa Medicare Ltd (SHILPAMED) ?
The 52-week low price of Shilpa Medicare Ltd (SHILPAMED) is Rs 417.6

ABOUT SHILPA MEDICARE

Shilpa Medicare Ltd, incorporated in the year 1987, has its registered office in #12-6-214/A1, Hyderabad Road, Raichur, Karnataka, 584135, 91-8532-238704, 91-8532238876. The main industry in which Shilpa Medicare Ltd operates is Pharmaceuticals - Indian - Formulations.

Auditor/Auditors for Shilpa Medicare Ltd is/are Bohara Bhandari Bung And Associates LLP. In the main management, Omprakash Inani is chairman and Ritu Tiwary is the company secretary for Shilpa Medicare Ltd.

  • OI Omprakash Inani Chairman (Non-Executive)
  • VB Vishnukant Bhutada Managing Director
  • SRK Sharath Reddy Kalakota Whole-time Director
  • AV Arvind Vasudeva Independent Director
  • HG Hetal Gandhi Independent Director
  • RT Ritu Tiwary Company Sec. & Compli. Officer
  • KKS Kamal K Sharma Independent Director
  • AB Anita Bandyopadhyay Independent Director

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement